Metraipolis › archive › dc_83cb9d4ab71f

Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases — Europe PMC PMID:42317359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42317359
DOI
10.3389/fimmu.2026.1864256
License (as archived)
solo-consultazione
Archived
2026-10-31T20:55:03.675Z
SHA-256 of the archived text
2300bb736edb60d2c3f2b5103fdccdb48017e0e2c3ea247e1bbf470c04fedf6f
Stable URL of this page
https://metraipolis.com/documento/dc_83cb9d4ab71f

How to cite

Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases — Europe PMC PMID:42317359 — Europe PMC (en), https://europepmc.org/article/MED/42317359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_83cb9d4ab71f (Metraipolis archive dc_83cb9d4ab71f, sha256 2300bb736edb60d2c3f2b5103fdccdb48017e0e2c3ea247e1bbf470c04fedf6f)
BibTeX
@misc{dc83cb9d4ab71f,
  title = {Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases — Europe PMC PMID:42317359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_83cb9d4ab71f; sha256 2300bb736edb60d2c3f2b5103fdccdb48017e0e2c3ea247e1bbf470c04fedf6f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317359. Agents can read the archived copy with the MCP tool read_document.